These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16380409)

  • 21. The laryngologist in organ preservation for laryngeal cancer.
    Brasnu DF; Hartl DM
    Laryngoscope; 2008 Apr; 118(4):759-60. PubMed ID: 18300709
    [No Abstract]   [Full Text] [Related]  

  • 22. Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma.
    Bradford CR; Wolf GT; Carey TE; Zhu S; Beals TF; Truelson JM; McClatchey KD; Fisher SG
    Otolaryngol Head Neck Surg; 1999 Nov; 121(5):534-8. PubMed ID: 10547465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organ preservation ... where do we stand?
    Lefebvre JL
    Acta Otorhinolaryngol Belg; 1999; 53(3):223-5. PubMed ID: 10635397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laryngeal preservation.
    Sturgis EM; Weiner RS; Miller RH
    J La State Med Soc; 1995 Jan; 147(1):9-16. PubMed ID: 7891003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients.
    Ijichi K; Hanai N; Kawakita D; Ozawa T; Suzuki H; Hirakawa H; Kodaira T; Murakami S; Hasegawa Y
    Jpn J Clin Oncol; 2014 Nov; 44(11):1063-9. PubMed ID: 25187666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent chemoradiotherapy as the most appropriate treatment for most T3 laryngeal carcinomas.
    Enepekides DJ
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):815-8. PubMed ID: 16172362
    [No Abstract]   [Full Text] [Related]  

  • 27. [Laryngeal neoplasms].
    Mozet C; Dietz A
    Laryngorhinootologie; 2010 May; 89(5):295-315. PubMed ID: 20458662
    [No Abstract]   [Full Text] [Related]  

  • 28. [Results of an organ conservation protocol in patients with locally advanced laryngeal tumours].
    León X; López M; García J; Quer M
    Acta Otorrinolaringol Esp; 2009; 60(3):176-85. PubMed ID: 19558903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
    Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
    Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
    Lefebvre JL; Ang KK;
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1293-303. PubMed ID: 19306746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of laryngeal cancer: the permanent challenge.
    Lefebvre JL; Coche-Dequéant B; Degardin M; Kara A; Mallet Y; Ton Van J
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):913-20. PubMed ID: 15485324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laryngeal preservation: what is the best treatment strategy?
    Hanna EY
    Curr Oncol Rep; 2004 May; 6(3):167-9. PubMed ID: 15066227
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined modality treatment of laryngeal squamous cell carcinoma.
    Devlin JG; Langer CJ
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):331-50. PubMed ID: 17338653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reexamining the treatment of advanced laryngeal cancer: the VA laryngeal cancer study revisited.
    Wolf GT
    Head Neck; 2010 Jan; 32(1):7-14. PubMed ID: 19953621
    [No Abstract]   [Full Text] [Related]  

  • 35. Reexamining the treatment of advanced laryngeal cancer.
    Olsen KD
    Head Neck; 2010 Jan; 32(1):1-7. PubMed ID: 19953627
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship between response to induction chemotherapy and disease control in patients with advanced laryngeal carcinoma included in an organ preservation protocol.
    León X; Valero C; Rovira C; Rodriguez C; López M; García-Lorenzo J; Quer M
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2581-2587. PubMed ID: 28349204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy for larynx preservation in patients with advanced laryngeal cancer.
    Andreadis C; Iliopoulou C; Sidiras T; Boutis A; Diamantopoulos N; Vahtsevanos K; Gennatas K; Mouratidou D
    J BUON; 2007; 12(3):341-7. PubMed ID: 17918287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From VA Larynx to the future of chemoselection: Defining the role of induction chemotherapy in larynx cancer.
    Spector ME; Rosko AJ; Swiecicki PL; Chad Brenner J; Birkeland AC
    Oral Oncol; 2018 Nov; 86():200-205. PubMed ID: 30409302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in laryngeal preservation study help increase accrual.
    Oncology (Williston Park); 1995 Nov; 9(11):1220. PubMed ID: 8703691
    [No Abstract]   [Full Text] [Related]  

  • 40. Options for preserving the larynx in patients with advanced laryngeal and hypopharyngeal cancer.
    Wolf GT
    Ear Nose Throat J; 2001 Dec; 80(12):897-901. PubMed ID: 11775526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.